

Carisma Therapeutics Inc., a biopharmaceutical company, has raised $59 million in Series B funding. The investors include IP Group Inc, Penn Medicine and 4BIO Capital.
Source: Press Release
Carisma Therapeutics Inc., a biopharmaceutical company, has raised $59 million in Series B funding.
Carisma Therapeutics Inc., a biopharmaceutical company, has raised $59 million in Series B funding. The investors include IP Group Inc, Penn Medicine and 4BIO Capital.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination